Construction of amphiphilic copolymer nanoparticles based on gelatin as drug carriers for doxorubicin delivery

Colloids and Surfaces B: Biointerfaces

Volumn 102, Issue , 2013, Pages 833-841

  Han, Siyuan ^a   Li, Mingjun ^b   Liu, Xiangang ^a   Gao, Hongxia ^b   Wu, Yan ^a  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b JIAMUSI UNIVERSITY   (China)

Author keywords

Antitumor activity; Biocompatibility; Drug delivery; Gelatin; Nanoparticles

Indexed keywords

AMPHIPHILIC COPOLYMERS; ANTI-TUMOR ACTIVITIES; ANTI-TUMORS; ANTITUMOR DRUGS; DOUBLE EMULSIONS; DOXORUBICIN; DOXORUBICIN HYDROCHLORIDE; DRUG CARRIER; ENCAPSULATION EFFICIENCY; FABRICATION METHOD; GELATIN; IN-VITRO; MODEL DRUGS; NANOCARRIERS; NANOPARTICLE SIZES; NANOPRECIPITATION METHOD; POLY LACTIDE; POLYMERIC NANOPARTICLES; RELEASE BEHAVIORS; RELEASE MEDIA; WEIGHT RATIOS;

BIOCOMPATIBILITY; COPOLYMERS; DRUG DELIVERY; EMULSIFICATION; ENCAPSULATION; ENZYME INHIBITION;

NANOPARTICLES;

AMPHOPHILE; DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; DOXORUBICIN; DRUG CARRIER; GELATIN; NANOPARTICLE; POLYLACTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIODEGRADABILITY; CANCER CELL CULTURE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG RELEASE; EMULSION; ENCAPSULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PH; PRECIPITATION; PRIORITY JOURNAL; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; GELATIN; HUMANS; MALE; MICE; MICE, INBRED BALB C; NANOPARTICLES; PHOSPHATIDYLETHANOLAMINES; POLYESTERS; POLYMERS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84867772171     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.09.010     Document Type: Article

References (37)

1. Allen T.M., Cullis P.R. Science 2004, 303:1818-1822.
2. LaVan D.A., McGuire T., Langer R. Nat. Biotechnol. 2003, 21:1184-1191.
3. Brigger I., Dubernet C., Couvreur P. Adv. Drug Deliv. Rev. 2002, 54:631-651.
4. Brannon-Peppas L., Blanchette J.O. Adv. Drug Deliv. Rev. 2004, 56:1649-1659.
5. Fahmy T.M., Fong P.M., Goyal A., Saltzman W.M. Mater. Today 2005, 8:18-26.
6. Avgoustakis K. Curr. Drug Deliv. 2004, 1:321-333.
7. Pan J., Venkatraman S.S., Feng M., Huat L. J. Control. Release 2005, 110:20-33.
8. Kato M., Toyoda H., Namikawa T., Hoshino M., Terai H., Miyamoto S., Ka T.K. Biomaterials 2006, 27:2035-2041.
9. Lee E.S., Kim D., Youn Y.S., Bae Y.H. J. Control. Release 2007, 123:19-26.
10. Yang F.L., Li X.G., Zhu F., Lei C.L. J. Agric. Food Chem. 2009, 57:10156-10162.
11. Busch S., Schwarz U., Kniep R. Adv. Funct. Mater. 2003, 13:189-198.
12. Kaul G., Amiji M. Pharm. Res. 2002, 19:1062-1068.
13. Chen T., Embree H.D., Wu L.Q., Payne G.F. Biopolymers 2002, 64:292-302.
14. Ma J., Cao H., Li Y., Li Y. J. Biomater. Sci. Polym. Ed. 2002, 13:67-80.
15. Ethirajan A., Schoeller K., Musyanovych A., Ziener U., Landfester K. Biomacromolecules 2008, 9:2383-2389.
16. Shutava T.G., Balkundi S.S., Vangala P., Steffan J.J., Bigelow R.L., Cardelli J.A., O'Neal D.P., Lvov Y.M. ACS Nano 2009, 3:1877-1885.
17. Wang T.W., Zhang C.L., Liang X.J., Liang W., Wu Y. J. Pharm. Sci. 2011, 100:1067-1079.
18. Lukyanov A.N., Gao Z.G., Mazzola L., Torchilin V.P. Pharm. Res. 2002, 19:1424-1429.
19. Gao Z., Lukyanov A.N., Anurag Singhal A., Torchilin V.P. Nano Lett. 2002, 2:979-987.
20. Wang X., Yang L., Chen Z., Shin D.M. CA. Cancer J. Clin. 2008, 58:97-110.
21. Kataoka K., Harada A., Nagasaki Y. Adv. Drug Deliv. Rev. 2001, 47:113-131.
22. Kim D., Gao Z.G., Lee E.S., Bae Y.H. Mol. Pharmaceutics 2009, 6:1353-1362.
23. Lu Y.J., Wei K.C., Ma C.C.M., Yang S.Y., Chen J.P. Colloids Surf. B: Biointerfaces 2012, 89:1-9.
24. Wu Y., Zheng Y.L., Yang W.L., Wang C.C., Hu J.H., Fu S.K. Carbohydr. Polym. 2005, 59:165-171.
25. Wang Z., Chui W.K., Ho P.C. Pharm. Res. 2009, 26:1162-1171.
26. Rodrigues J.S., Santos-Magalhaes N.S., Coelho L.C.B.B., Couvreur P., Ponchel G., Gref R. J. Control. Release 2003, 92:103-112.
27. Govender T., Stolnik S., Garnett M.C., Illum L., Davis S.S. J. Control. Release 1999, 57:171-185.
28. Tian Q., Zhang C.N., Wang X.H., Wang W., Huang W., Cha R.T., Wang C.H., Yuan Z., Liu M., Wan H.Y., Tang H. Biomaterials 2010, 31:4748-4756.
29. Jeong Y.I., Cheon J.B., Kim S.H., Nah J.W., Lee Y.M., Sung Y.K., Akaike T., Cho C.S. J. Control. Release 1998, 51:169-178.
30. Zhang W.F., Chen X.G., Li P.W., He Q.Z., Zhou H.Y. J. Mater. Sci. Mater. Med. 2008, 19:305-310.
31. Mazumder B., Dey S., Bhattacharya S., Sarkar S., Mohanta B. Arch. Pharm. Sci. Res. 2009, 1:66-74.
32. Gerasimov O.V., Boomer J.A., Qualls M.M., Thompson D.H. Adv. Drug Deliv. Rev. 1999, 38:317-338.
33. Bae Y., Fukushima S., Harada A., Kataoka K. Angew. Chem. Int. Ed. 2003, 42:4640-4643.
34. Ubrich N., Bouillot Ph., Pellerin C., Hoffman M., Maincent Ph. J. Control. Release 2004, 97:291-300.
35. Malzert A., Boury F., Saulnier P., Benoit J.P., Proust J.E. Langmuir 2001, 17:7837-7841.
36. Kakizawa Y., Kataoka K. Adv. Drug Deliv. Rev. 2002, 54:203-222.
37. Tang N., Du G.J., Wang N., Liu C.C., Hang H.Y., Liang W. J. Natl. Cancer Inst. 2007, 99:1004-1015.